Michael Grieco

Michael Grieco has a diverse work experience in the field of analytical development, starting from 2008 to the present. Michael currently holds the position of Associate Director of Analytical Development at Kura Oncology, Inc. which they started in October 2022. Prior to this, they worked as Associate Director of Analytical at Nuvation Bio from September 2020 to August 2022. In their role, they supported analytical drug development activities and managed multiple vendors.

Before joining Nuvation Bio, Grieco held various roles at Particle Sciences, A Lubrizol Life Science Company. Michael was an Associate Director from February 2019 to August 2020, an Analytical Services Manager from April 2016 to February 2019, and an Analytical Chemist from December 2011 to April 2016.

From April 2010 to December 2011, Grieco worked as a Quality Control Technician at Medical Diagnostic Laboratories, L.L.C. (MDL). Prior to that, they were a Laboratory Analyst at Accutest Labs Inc from June 2008 to December 2011.

Michael Grieco attended Rutgers University–New Brunswick, where they pursued a degree in Biological Sciences. No specific start or end dates for their education at this institution are mentioned.